Michael J. Schlosser - 29 Oct 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Nov 2026, 17:52:45 UTC
Prior SEC filing
11 Sep 2026
Next SEC filing
06 Nov 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kevin A. Ball, Attorney-in-Fact
Filing notes and source

Key filing fact

Michael J. Schlosser filed Form 4 for HCA Healthcare, Inc. (HCA) on 02 Nov 2026.

Key facts

  • This page summarizes Michael J. Schlosser's Form 4 filing for HCA Healthcare, Inc. (HCA).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 02 Nov 2026, 17:52.

Change

  • Previous filing in this sequence was filed on 11 Sep 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002149484 Primary reporting owner

Schlosser Michael J

Relationship
EVP and Chief Clinical Officer
Address
ONE PARK PLAZA, NASHVILLE
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Signature date
02 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCA transaction

Common Stock

Options Exercise

Transaction value
Shares
+3,030
Change %
+1781%
Price
$81.96*
Shares after
3,200
Date
29 Oct 2026
Ownership
Direct
HCA transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,898
Change %
+59%
Price
$82.85*
Shares after
5,098
Date
29 Oct 2026
Ownership
Direct
HCA transaction

Common Stock

Tax liability

Transaction value
Shares
-2,455
Change %
-48%
Price
$478.08*
Shares after
2,643
Date
29 Oct 2026
Ownership
Direct
HCA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,951
Date
29 Oct 2026
Ownership
By 2022 Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HCA transaction Derivative

Stock Appreciation Right

Options Exercise

Transaction value
Shares
-3,030
Change %
-100%
Price
$0.000000*
Shares after
0
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,030
Exercise price
$81.96
Footnotes
F1
HCA transaction Derivative

Stock Appreciation Right

Options Exercise

Transaction value
Shares
-1,898
Change %
-100%
Price
$0.000000*
Shares after
0
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,898
Exercise price
$82.85
Footnotes
F2
HCA transaction Derivative

Stock Appreciation Right

Award

Transaction value
Shares
+2,797
Change %
Price
$0.000000*
Shares after
2,797
Date
29 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,797
Exercise price
$478.08
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.

Footnote F2

The stock appreciation rights vested in four equal annual installments beginning on May 3, 2018.

Footnote F3

The stock appreciation rights vest in four equal annual installments beginning on October 29, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .